Cancer Biotherapy and Radiopharmaceuticals

Papers
(The H4-Index of Cancer Biotherapy and Radiopharmaceuticals is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Expression of HER2 and BRCA1 Correlates with Prognosis in Patients with Breast Cancer After Radiotherapy: A Case–Control Study30
Long Noncoding RNA Regulator of Reprogramming Regulates Cell Growth, Metastasis, and Cisplatin Resistance in Gastric Cancer via miR-519d-3p/HMGA2 Axis29
IL-21 and IL-33 May Be Effective Biomarkers to Predict the Efficacy of PD-1 Monoclonal Antibody for Advanced Cholangiocarcinoma27
LncRNA MORT Overexpression Inhibits Cancer Cell Migration and Invasion in Hepatocellular Carcinoma by Downregulating NOTCH127
Retraction of: Targeted Regulation of FoxO3a by miR-372 to Mediate Gastric Carcinoma Cell Apoptosis and DDP Drug Resistance (doi: 10.1089/cbr.2019.3299)23
Knockdown of Circ_CCNB2 Sensitizes Prostate Cancer to Radiation Through Repressing Autophagy by the miR-30b-5p/KIF18A Axis21
Efficacy and Safety of Drug-Eluting Beads Bronchial Arterial Chemoembolization in Treating Patients with Lung Cancer Who Were Complicated with Hemoptysis20
miR-146a Enhances the Sensitivity of Breast Cancer Cells to Paclitaxel by Downregulating IRAK118
Serum-Derived Exosomes-Mediated Circular RNA ARHGAP10 Modulates the Progression of Non-Small Cell Lung Cancer Through the miR-638/FAM83F Axis18
Potential Theranostic Boron Neutron Capture Therapy Agents as Multimodal Radiopharmaceuticals17
Chelation-Tamoxifen Conjugates for Imaging of Estrogen Receptors17
Long Non-Coding RNA AC008972.1 as a Novel Therapeutic Target for Prostate Cancer16
An LNM-Associated Gene Signature for Prognostic Prediction and Immune Profiling in Head and Neck Squamous Cell Carcinoma16
Clinical Significance of Integrin Subunit Beta 4 in Head and Neck Squamous Cell Carcinoma15
circKLHL24 Blocks Breast Cancer Development by Regulating the miR-1204/ALX4 Network15
MiR-424 Acts as a Novel Biomarker in the Diagnosis of Patients with Hepatocellular Carcinoma15
0.134113073349